First reported case of multidrug-resistant Candida auris in Canada.

about

Candida auris, what do paediatricians need to know?Genomic epidemiology of the UK outbreak of the emerging human fungal pathogen Candida auris.Epidemiology, clinical characteristics, resistance, and treatment of infections by

P2860

Q51149128-B862128F-B1BB-49E5-A6C2-83C7B6FC5594 Q51782762-90ADAC6B-3BE9-49E2-9A2D-AF2A9D0BED57 Q58598193-8D5570AB-8EEC-47E8-A4F4-4F373F5447A5

P2860

First reported case of multidrug-resistant Candida auris in Canada.

Item

http://www.wikidata.org/entity/Q55017741

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

First reported case of multidrug-resistant Candida auris in Canada.

@en

First reported case of multidrug-resistant Candida auris in Canada.

@nl

type

Item

label

First reported case of multidrug-resistant Candida auris in Canada.

@en

First reported case of multidrug-resistant Candida auris in Canada.

@nl

prefLabel

First reported case of multidrug-resistant Candida auris in Canada.

@en

First reported case of multidrug-resistant Candida auris in Canada.

@nl

P1476

First reported case of multidrug-resistant Candida auris in Canada

@en

P2093

G W Hammond

http://www.w3.org/2001/XMLSchema#string

I S Schwartz

http://www.w3.org/2001/XMLSchema#string

P2860

Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital.

Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally.

First hospital outbreak of the globally emerging Candida auris in a European hospital

Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses.

Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek

Multidrug-Resistant Candida haemulonii and C. auris, Tel Aviv, Israel.

Candida auris candidaemia in Indian ICUs: analysis of risk factors.

The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation.

Multidrug-resistant endemic clonal strain of Candida auris in India.

Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris.

P304

150-153

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.14745/CCDR.V43I78A02

http://www.w3.org/2001/XMLSchema#string

P433

7-8

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29770082

http://www.w3.org/2001/XMLSchema#string

P921

Canada

Candida auris

multiple drug resistance

P932

5764715

http://www.w3.org/2001/XMLSchema#string

First reported case of multidrug-resistant Candida auris in Canada.

about

P2860

P2860

First reported case of multidrug-resistant Candida auris in Canada.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932